Those products exist in a legal grey area, carry real safety risks, and have zero accountability if something goes wrong
For complete regulatory framework coverage, see Are Peptides Legal in Canada
(24) Preclinical animal models demonstrated that GLP-1 receptor agonists may help protect against fractures and reduce advanced glycation end-product (AGE) accumulation in diabetic subjects
Certificate of Analysis for every lot Listed report available for batch QYA055
Commodore-Mensah Y, Loustalot F, Himmelfarb CD, Desvigne-Nickens P, Sachdev V, Bibbins-Domingo K, Clauser SB, Cohen DJ, Egan BM, Fendrick AM, Ferdinand KC, Goodman C, Graham GN, Jaffe MG, Krumholz HM , Levy PD, Mays GP, McNellis R, Muntner P, Ogedegbe G, Milani RV, Polgreen LA, Reisman L, Sanchez EJ, Sperling LS, Wall HK, Whitten L, Wright JT, Wright JS, Fine LJ